Overview

Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse

Status:
Unknown status

Trial end date:
2015-12-01

Target enrollment:
0

Participant gender:
All

Summary

Background- Idiopathic Nephrotic syndrome is the common glomerular disease in childhood. conventional treatment is steroid treatment and nearly 90% response to this treatment well. Response to this treatment is the most important prognostic factor and this patients has a benign disease course. 60-70% among patients that response to steroid treatment,will suffer a relapse of NS.repeated steroids courses can lead to serious adverse events in children such as low bone density,weight gain ,growth slow down ,elevated blood pressure and eye pressure.there is side effect corelation between steroid dose and treatment duration. guidelines for steroid dose for NS relapse are not based on retrospective clinical research but only on Nephrologists and experts opinion. Rational- What would be the optimal low dose steroids and the shortest time of treatment in Nephrotic syndrome relapse?

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Rabin Medical Center

Treatments:

Prednisone

Criteria

Inclusion Criteria:

- Patients with Idiopathic nephrotic syndrome with a flair that needs steroids
treatment.

Exclusion Criteria:

- Steroid resistance or treatment with Cyclosporin or Cellcept